News about Global Pharma

GT Medical Technologies Appoints James Leech as Chief Financial and Strategy Officer

GT Medical Technologies announced that James Leech, a seasoned financial and operational life sciences leader, has joined the company as Chief Financial and Strategy Officer.

Global Pharma | 11/06/2025 | By Manvi |  168

FDA-Approved WiSE System Begins US Rollout for Leadless Heart Pacing

In a major milestone for heart failure treatment, the first commercial patients in the US have been successfully implanted with the FDA-approved WiSE® System—marking the beginning of a new chapter in leadless left ventricular endocardial pacing (LVEP) for the treatment of heart failure.

Global Pharma | 11/06/2025 | By Manvi |  104

Okomera Opens Pre-Orders for its First Commercial System 'Ocentra'

Okomera opened pre-orders for its first commercial system, Ocentra, unveiled live at the MPS World Summit in Brussels (10–12 June) and Vivatech Paris (11–14 June).

Global Pharma | 10/06/2025 | By Manvi |  310

Solventum Launches Attest Super Rapid VH2O2 Clear Challenge Pack

Solventum, a global MedTech leader at the forefront of infection prevention innovation, announced the launch of its Attest™ Super Rapid Vaporized Hydrogen Peroxide (VH2O2) Clear Challenge Pack.

Global Pharma | 10/06/2025 | By Manvi |  218

WuXi Biologics Collaborates with VISEN Pharmaceuticals to Manufacture Lonapegsomatropin at Chengdu Microbial Manufacturing Site

WuXi Biologics and VISEN Pharmaceuticals have initiated the technology transfer for local commercial production of lonapegsomatropin in China, marking a key milestone in their strategic collaboration to advance treatment for pediatric growth hormone deficiency.

Global Pharma | 10/06/2025 | By Manvi |  176

Global Data: Trump's move to transform US pharma manufacturing raises doubts over its effectiveness

This directive, which instructs the FDA to expedite the approval process for US pharmaceutical facilities, has ignited a wave of skepticism within the industry regarding its potential effectiveness, says GlobalData.

Global Pharma | 10/06/2025 | By Darshana |  211

Glenmark Pharmaceuticals to Launch DCGI-Approved BRUKINSA in India for Treating Blood Cancers

Glenmark Pharmaceuticals has announced the upcoming launch of zanubrutinib (BRUKINSA) in India, following DCGI approval, offering a new treatment option for five types of B-cell blood cancers.

Global Pharma | 09/06/2025 | By Manvi |  336

Lupin Secures Tentative Approval from US FDA for Oxcarbazepine ER Tablets

Lupin has received tentative approval from the US FDA for its Oxcarbazepine Extended-Release Tablets in 150 mg, 300 mg, and 600 mg strengths, to be manufactured at its Nagpur facility for the treatment of partial-onset seizures.

Global Pharma | 09/06/2025 | By Manvi |  132

Spineart Launches SCARLET AC-Ti Secured Anterior Cervical Cage in US

Spineart announces the full-market launch of its SCARLET® AC-Ti secured anterior cervical cage in the United States.

Global Pharma | 09/06/2025 | By Manvi |  378

AMDI Completes Clinical Study for Fast PCR Mini Respiratory Panel

Autonomous Medical Devices Incorporated (AMDI) announced the successful completion of its multicenter clinical study supporting FDA submission of its Mini Respiratory Panel. The respiratory panel is the first test developed for its Fast PCR system.

Global Pharma | 09/06/2025 | By Manvi |  208